Citigroup

Coherus Announces Proposed Public Offering of Common Stock

Retrieved on: 
Monday, May 15, 2023

REDWOOD CITY, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that it has commenced an underwritten public offering of $50.0 million of shares of its common stock.

Key Points: 
  • REDWOOD CITY, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that it has commenced an underwritten public offering of $50.0 million of shares of its common stock.
  • In addition, Coherus expects to grant the underwriters a 30-day option to purchase up to an additional $7.5 million of shares of its common stock at the public offering price, less the underwriting discount.
  • All of the shares of common stock to be sold in the offering will be offered by Coherus.
  • The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the proposed offering may be completed, or as to the actual size or terms of the proposed offering.

Consello Appoints Mark Shafir as Managing Partner of its M&A Advisory and Investment Banking Business

Retrieved on: 
Monday, May 15, 2023

NEW YORK, May 15, 2023 /PRNewswire/ -- Consello, the financial services advisory and strategic investing platform, is pleased to announce the appointment of Mark Shafir as Managing Partner of the company's M&A Advisory and Investment Banking business.

Key Points: 
  • NEW YORK, May 15, 2023 /PRNewswire/ -- Consello, the financial services advisory and strategic investing platform, is pleased to announce the appointment of Mark Shafir as Managing Partner of the company's M&A Advisory and Investment Banking business.
  • Mr. Shafir has more than 38 years of experience working on Wall Street overseeing top investment banking teams and advising leading corporations on many of the world's largest and most high-stakes transactions.
  • Before joining Consello, Mr. Shafir was the Co-Head of Global Mergers & Acquisitions at Citigroup.
  • The company currently has four operating divisions, including M&A Advisory and Investment Banking, Investing, Growth and Business Development and Digital Assets Advisory.

 Pfizer Announces Proposed Notes Offering

Retrieved on: 
Monday, May 15, 2023

Pfizer Inc. (NYSE: PFE) (“Pfizer”) today announced that its wholly owned subsidiary, Pfizer Investment Enterprises Pte.

Key Points: 
  • Pfizer Inc. (NYSE: PFE) (“Pfizer”) today announced that its wholly owned subsidiary, Pfizer Investment Enterprises Pte.
  • Ltd. (the “Issuer”), has commenced a multi-series offering of senior unsecured notes (the “Notes”).
  • The Notes will be fully and unconditionally guaranteed on a senior unsecured basis by Pfizer.
  • Pfizer intends to use the net proceeds of the offering as part of the financing for Pfizer’s proposed acquisition of Seagen Inc. (the “Merger”).

Mirion Technologies Announces Pricing of Public Offering by Selling Stockholders

Retrieved on: 
Friday, May 12, 2023

Mirion Technologies, Inc. (“Mirion,” “we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the pricing of an underwritten public offering of 7,000,000 shares of Mirion’s Class A common stock by certain selling stockholders at a price to the public of $7.65 per share.

Key Points: 
  • Mirion Technologies, Inc. (“Mirion,” “we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the pricing of an underwritten public offering of 7,000,000 shares of Mirion’s Class A common stock by certain selling stockholders at a price to the public of $7.65 per share.
  • Selling stockholders participating in the offering consist of entities affiliated with Charterhouse Capital Partners.
  • Mirion will not sell any securities in the public offering and will not receive any of the proceeds from the sale of the shares being offered by the selling stockholders, but Mirion will bear the costs associated with the public offering, other than underwriting discounts and commissions and certain other expenses.
  • Before you invest, you should read the prospectus in the registration statement and the other documents Mirion has filed or will file with the SEC for more complete information about Mirion and this offering.

Citi LIBOR Transition Update

Retrieved on: 
Friday, May 12, 2023

The USD LIBOR ICE Swap Rate is also referred to as a constant maturity swap (or “CMS”) rate, and in this press release is referred to as the “USD LIBOR CMS Rate”.

Key Points: 
  • The USD LIBOR ICE Swap Rate is also referred to as a constant maturity swap (or “CMS”) rate, and in this press release is referred to as the “USD LIBOR CMS Rate”.
  • Citi is issuing this press release to provide notice that, after the Cessation Date, it expects that calculations referencing the USD LIBOR CMS Rate in the Legacy CMS Instruments will no longer be calculated by reference to the USD LIBOR CMS Rate, but instead will be calculated pursuant to the applicable fallback provisions described below.
  • As it is expected that the USD LIBOR CMS Rate will not be published following the Cessation Date, the calculation agent intends following the Cessation Date to request quotations for USD interest rate swap transactions referencing USD LIBOR, as described above.
  • Annex 2 lists Legacy CMS Instruments containing fallback provisions that provide that, if the calculation and publication of the relevant USD LIBOR CMS Rate is permanently canceled, then the calculation agent may replace that USD LIBOR CMS Rate with an alternative rate that it determines, in its sole discretion, represents the same or a substantially similar measure or benchmark as that USD LIBOR CMS Rate.

Mirion Technologies Announces Proposed Public Offering by Selling Stockholders

Retrieved on: 
Thursday, May 11, 2023

Mirion Technologies, Inc. (“Mirion,” “we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the commencement of an underwritten public offering of 7,000,000 shares of Mirion’s Class A common stock by certain selling stockholders.

Key Points: 
  • Mirion Technologies, Inc. (“Mirion,” “we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the commencement of an underwritten public offering of 7,000,000 shares of Mirion’s Class A common stock by certain selling stockholders.
  • Selling stockholders participating in the offering consist of entities affiliated with Charterhouse Capital Partners.
  • Mirion will not sell any securities in the proposed offering and will not receive any of the proceeds from the sale of the shares being offered by the selling stockholders, but Mirion will bear the costs associated with the proposed offering, other than underwriting discounts and commissions and certain other expenses.
  • The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.

Metals Acquisition Corp Announces Effectiveness of Form F-4 Registration Statement and $26 million of Additional PIPE Subscription Agreements Executed for a Total of $140 million

Retrieved on: 
Thursday, May 11, 2023

MAC will mail the definitive proxy statement/prospectus to shareholders of record as of the close of business on May 5, 2023.

Key Points: 
  • MAC will mail the definitive proxy statement/prospectus to shareholders of record as of the close of business on May 5, 2023.
  • MAC shareholders of record as of the close of business on May 5, 2023 are entitled to attend and vote at the Special Meeting.
  • The Business Combination is expected to close shortly after shareholder approval at the Special Meeting, subject to the satisfaction of other customary closing conditions.
  • The executed Subscription Agreements now total approximately $140 million, surpassing MAC's initial fundraising target of $126 million.

EQS-News: Skyborn Renewables appoints new CFO and CInO

Retrieved on: 
Thursday, May 11, 2023

Willem Mentz has been appointed as Skyborn Renewables' Chief Financial Officer (CFO), and Bill Gutterman has been appointed as Chief Investment Officer (CInO), effective 15 May 2023.

Key Points: 
  • Willem Mentz has been appointed as Skyborn Renewables' Chief Financial Officer (CFO), and Bill Gutterman has been appointed as Chief Investment Officer (CInO), effective 15 May 2023.
  • They will be replacing João Metelo, who currently holds the position of Chief Investment & Financial Officer (CIFO) and has decided to exit Skyborn.
  • Willem Mentz, CFO (left) and Bill Gutterman, CInO (right)
    “At Skyborn, we are committed to creating a leading offshore wind platform and contributing to the global energy transition.
  • We are delighted to welcome Willem and Bill to our Executive Team," commented Thomas Karst, CEO of Skyborn.

Citigroup Announces $1.5 Billion Redemption of 1.678% Fixed Rate / Floating Rate Notes due 2024

Retrieved on: 
Wednesday, May 10, 2023

Citigroup Inc. is announcing the redemption, in whole, constituting $1,500,000,000 of its 1.678% Fixed Rate / Floating Rate Notes due 2024 (the “notes”) (ISIN: US172967MR94).

Key Points: 
  • Citigroup Inc. is announcing the redemption, in whole, constituting $1,500,000,000 of its 1.678% Fixed Rate / Floating Rate Notes due 2024 (the “notes”) (ISIN: US172967MR94).
  • The redemption date for the notes is May 15, 2023 (the “redemption date”).
  • The cash redemption price for the notes payable on the redemption date will equal par plus accrued and unpaid interest, to but excluding, the redemption date.
  • Beginning on the redemption date, interest will no longer accrue on the notes.

HYZON MOTORS ANNOUNCES APPOINTMENT OF ANDREA FARACE TO BOARD OF DIRECTORS

Retrieved on: 
Wednesday, May 10, 2023

ROCHESTER, N.Y., May 10, 2023 /PRNewswire/ -- Hyzon Motors Inc. (NASDAQ: HYZN), a global supplier of zero-emission heavy-duty fuel cell electric vehicles, today announced the appointment of Andrea Farace to its Board of Directors, effective May 4, 2023.

Key Points: 
  • ROCHESTER, N.Y., May 10, 2023 /PRNewswire/ -- Hyzon Motors Inc. (NASDAQ: HYZN), a global supplier of zero-emission heavy-duty fuel cell electric vehicles, today announced the appointment of Andrea Farace to its Board of Directors, effective May 4, 2023.
  • Farace will serve on the Nominating and Governance Committee as an independent director.
  • Farace is an accomplished executive and leader with a long career in finance and general business management.
  • "Andrea brings extensive expertise in finance and governance to the Hyzon Board of Directors, gained from his work as corporate executive and through advisory capacities as board member," said Elaine Wong, Hyzon's Lead Independent Director.